Senior Advisor to the President at DANA FARBER CANCER INSTITUTE INC
Bruce E. Johnson, MD, was Dana-Farber’s chief clinical research officer from 2013 until 2021. He previously was director of the Lowe Center for Thoracic Oncology at Dana-Farber Brigham Cancer Center. He is also professor of Medicine at Harvard Medical School and an American Society of Clinical Oncology translational research professor. Dr. Johnson is serving as co-director of the Center for Cancer Genomics (CCG). Dr. Johnson graduated from Harvard University and the University of Minnesota Medical School. His postdoctoral training was at the University of Chicago Hospitals and Clinics and the National Cancer Institute. In 1992, he became head of the Lung Cancer Biology Section, Medicine Branch, at the NCI, until 1998, when he joined Dana-Farber. Dr. Johnson is currently serving as president of the American Society of Clinical Oncology. Dr. Johnson directs the Lung Cancer Program within the Dana-Farber/Harvard Cancer Center. His translational research is devoted to testing novel therapeutic agents for their efficacy against lung cancer and other thoracic malignancies with specific genomic changes.
Source: DANA FARBER CANCER INSTITUTE INC on 06/24/2022
By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Bruce Johnson. More specifically, you'll be able to:
Access over 2,000,000 executive and board member profiles.
Example: Bruce Johnson